Patient education and oral anticoagulant therapy
- PMID: 12368164
Patient education and oral anticoagulant therapy
Abstract
Background and objectives: The stability of oral anticoagulant therapy is affected by an irregular intake of vegetables, interactions with other drugs, intercurrent disease, and compliance. With the aim of investigating whether educating patients could affect anticoagulation stability, we prepared a questionnaire on the basis of some fundamental information given by us to our patients during their first attendance to our clinic. Moreover we sought to determine whether administering the questionnaire would be useful in improving the anticoagulation stability of patients whose anticoagulation was poorly controlled.
Design and methods: The questionnaire was administered to a group of 219 anticoagulated patients attending our Thrombosis Center. All patients were invited to fill in the questionnaire, which was handed out by a nurse, while they were waiting for their blood sampling results. None of the patients refused to fill in the questionnaire, which was completed at once and independently. The answers to the questionnaire were correlated with the time spent by the patients in the therapeutic range.
Results: A significant difference was found between the time spent in the therapeutic range by patients who declared a regular intake of their therapy (91%, 14-100%) and that spent in the range by those who answered they sometimes forgot to take it (75%, 9-100%). The percentage of time spent in the therapeutic range was significantly longer (92%, 36%-100%) in patients who reported regular vegetable intake and in those that never ate vegetables than that observed in patients who admitted occasional intake of vegetables (86%, 5%-100%). In the group of patients below 65 years of age, a significant difference in the time spent in the therapeutic range was observed in the case of regular assumption of oral anticoagulant drugs (95% vs 68%, p<0.01) and in that of regular daily vegetable intake (95% vs 86%, p=0.03). The difference in time spent in the range between patients who knew why they were taking the oral anticoagulant and those who did not was statistically significant only in the older group (89% vs 76%, p=0.04). In women, the time spent in the therapeutic range depended on regular vegetable intake (92% vs 74%, p=0.02), assumption of other drugs (91% vs 72%, p=0.02), and intercurrent disease (92% vs 76%, p=0.04). In men a significant difference was observed in favor of those who knew why they were taking oral anticoagulants (93% vs 83%, p<0.01). Logistic regression analysis showed that the risk of being below the chosen cut-off of the time in range (90%) was 6.0 (C.I. 95%: 2.2-16.3) in those patients who sometimes forgot their daily dose even though they knew why they were taking the oral anticoagulant. Moreover, the risk of being below the cut-off was 3.0 (C.I. 95%: 1.3-6.5) in those who never forgot to take their therapy, but did not know the reason why they were taking oral anticoagulants. Finally we observed a significant improvement in the time spent in the range by patients with poor anticoagulation control when we included the three months before and after the questionnaire in our analysis.
Interpretation and conclusions: In conclusion we believe: 1) that greater emphasis should be given to educational courses for anticoagulated patients especially in consideration of age and gender differences; and 2) on its own, administration of the questionnaire leads to a significant improvement in the time spent by patients in the therapeutic range.
Similar articles
-
Assessment of patient capability to self-adjust oral anticoagulant dose: a multicenter study on home use of portable prothrombin time monitor (COAGUCHECK).Haematologica. 2000 Aug;85(8):826-31. Haematologica. 2000. PMID: 10942929
-
[Educational role of community nurse in care of patients treated with oral anticoagulation therapy].Pol Merkur Lekarski. 2009 Jun;26(156):636-9. Pol Merkur Lekarski. 2009. PMID: 19711731 Polish.
-
Patients' perceptions regarding oral anticoagulation therapy and its effect on quality of life.Curr Med Res Opin. 2005 Jul;21(7):1085-90. doi: 10.1185/030079905X50624. Curr Med Res Opin. 2005. PMID: 16004677
-
Oral anticoagulant therapy--50 years later.Arch Intern Med. 1993 Mar 8;153(5):586-96. Arch Intern Med. 1993. PMID: 8439222 Review.
-
State-of-the-art patient self-management for control of oral anticoagulation.Semin Thromb Hemost. 1999;25(1):43-7. doi: 10.1055/s-2007-996423. Semin Thromb Hemost. 1999. PMID: 10327220 Review.
Cited by
-
Lacunae in patient knowledge about oral anticoagulant treatment: results of a questionnaire survey.Indian J Hematol Blood Transfus. 2015 Jun;31(2):275-80. doi: 10.1007/s12288-014-0415-z. Epub 2014 Jun 13. Indian J Hematol Blood Transfus. 2015. PMID: 25825572 Free PMC article.
-
Bleeding and asymptomatic overdose in patients under Vitamin K antagonist therapy: Frequency and risk factors.Egypt Heart J. 2018 Mar;70(1):45-49. doi: 10.1016/j.ehj.2018.01.001. Epub 2018 Feb 1. Egypt Heart J. 2018. PMID: 29622997 Free PMC article.
-
Best strategies for patient education about anticoagulation with warfarin: a systematic review.BMC Health Serv Res. 2008 Feb 14;8:40. doi: 10.1186/1472-6963-8-40. BMC Health Serv Res. 2008. PMID: 18275605 Free PMC article.
-
Thyroid, hemostasis and thrombosis.J Endocrinol Invest. 2004 Dec;27(11):1065-71. doi: 10.1007/BF03345311. J Endocrinol Invest. 2004. PMID: 15754740 Review.
-
Predictive factors for obtaining a correct therapeutic range using antivitamin K anticoagulants: a tertiary center experience of patient adherence to anticoagulant therapy.Patient Prefer Adherence. 2015 Sep 8;9:1271-8. doi: 10.2147/PPA.S87066. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26388689 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials